Interestingly, Yan et al. demonstrated that STEAP4 was decreased in bladder cancer, and the competition between STEAP4 and CircPICALM combined with miR-1265 will affect the EMT process in bladder cancer cells [57]. Here, STEAP4 is linked to urinary bladder carcinoma.